These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6581638)

  • 1. The treatment of ciliary body melanoma by beta radiation.
    Foerster MH; Wessing A; Meyer-Schwickerath G
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():64-7. PubMed ID: 6581638
    [No Abstract]   [Full Text] [Related]  

  • 2. [A beta ray applicator (106Ru/106Rh) in the treatment of ciliary body melanomas].
    Ballin R; Lommatzsch PK; Drost H; Ratajek B
    Klin Monbl Augenheilkd; 1985 Aug; 187(2):144-6. PubMed ID: 4057906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The potential for organ-preserving treatment in large uveal melanoma].
    Terent'eva LS; Fokin VP
    Oftalmol Zh; 1989; (6):338-41. PubMed ID: 2622597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of malignant melanomas of the uvea with 106-ruthenium applicators. Report on the first 100 Essen cases].
    Foerster MH; Bornfeld N; Wessing A; Schulz U; Schmitt G; Meyer-Schwickerath G
    Klin Monbl Augenheilkd; 1984 Dec; 185(6):490-4. PubMed ID: 6527503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
    Razzaq L; de Keizer RJ
    Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
    Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-Curie contact therapy in the conservative treatment of uveal melanoma. Evaluation of the first 100 cases treated].
    Grange JD
    Bull Soc Belge Ophtalmol; 1988; 229():15-21. PubMed ID: 3273250
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combined radiotherapy of uveal melanoma].
    Brovkina AF; Kesheleva VV; Fridman FE; Fishkin IG
    Vestn Oftalmol; 1997; 113(2):10-2. PubMed ID: 9229894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Echographic evaluation of malignant melanoma of the uvea following ruthenium therapy].
    Kissinger A; Bornfeld N; Foerster MH; Gerke E; Wessing A; Meyer-Schwickerath G
    Fortschr Ophthalmol; 1986; 83(6):721-5. PubMed ID: 3546039
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation therapy for uveal melanomas involving the ciliary body.
    Char DH
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 2)():252-6. PubMed ID: 3467500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy.
    Muen WJ; Damato BE
    Eye (Lond); 2007 Feb; 21(2):307-8. PubMed ID: 16946742
    [No Abstract]   [Full Text] [Related]  

  • 13. [Report on 50 cases of uveal melanoma treated by conservative beta curietherapy].
    Grange JD; Bonnet M; Bievelez B; Jean-Louis B; Quintero P; Santamaria E; Guillaubey Y; Gérard JP; Delaroche G; Mere P
    Bull Soc Ophtalmol Fr; 1987 Nov; 87(11):1297-300. PubMed ID: 3451841
    [No Abstract]   [Full Text] [Related]  

  • 14. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panophthalmitis with acute scleral necrosis after brachytherapy of a malignant melanoma of the ciliary body.
    Bodanowitz S; Strempel I; Wiegand W; Kroll P
    Ger J Ophthalmol; 1995 Nov; 4(6):380-2. PubMed ID: 8751105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
    Busse H; Müller RP
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():72-7. PubMed ID: 6581639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques.
    Kleineidam M; Guthoff R
    Ger J Ophthalmol; 1994 Jan; 3(1):22-5; discussion 25-6. PubMed ID: 8142877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences in the treatment of malignant melanoma of the choroid with 106Ru-106Rh beta-ray applicators.
    Lommatzsch PK
    Trans Ophthalmol Soc U K (1962); 1973; 93(0):119-32. PubMed ID: 4526435
    [No Abstract]   [Full Text] [Related]  

  • 20. [Visual acuity after surgical management of ciliary body melanoma].
    Romanowska-Dixon B
    Klin Oczna; 2005; 107(10-12):632-4. PubMed ID: 16619807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.